SOLENO THERAPEUT. DL-001 (6XC) - Cash Flow Conversion Efficiency

Latest as of December 2025: 0.108x

Based on the latest financial reports, SOLENO THERAPEUT. DL-001 (6XC) has a cash flow conversion efficiency ratio of 0.108x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€48.70 Million ≈ $56.94 Million USD) by net assets (€450.12 Million ≈ $526.23 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See 6XC equity financing ratio to measure how much of total assets are equity-financed.

SOLENO THERAPEUT. DL-001 - Cash Flow Conversion Efficiency Trend (2021–2025)

This chart illustrates how SOLENO THERAPEUT. DL-001's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check earnings quality score of SOLENO THERAPEUT. DL-001 to evaluate the quality of earnings relative to operating cash generation.

SOLENO THERAPEUT. DL-001 Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of SOLENO THERAPEUT. DL-001 ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
TAV HAVALIMAN.HLDG ADR/4 F:5THA	-0.065x
Enerflex Ltd. TO:EFX	0.046x
BRP Inc. NASDAQ:DOO	0.606x
Affle (India) Limited NSE:AFFLE	0.056x
Angang Steel Co Ltd Class A SHE:000898	0.033x
Saigon Beer Alcohol Beverage Corp VN:SAB	0.101x
Changzhou Fusion New Material Co. Ltd. A SHG:688503	N/A
Pharma Reaserch Prod Co Ltd KQ:214450	0.085x

Annual Cash Flow Conversion Efficiency for SOLENO THERAPEUT. DL-001 (2021–2025)

The table below shows the annual cash flow conversion efficiency of SOLENO THERAPEUT. DL-001 from 2021 to 2025. For the full company profile with market capitalisation and key ratios, see how much is SOLENO THERAPEUT. DL-001 worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	€450.12 Million ≈ $526.23 Million	€46.80 Million ≈ $54.71 Million	0.104x	+136.88%
2024-12-31	€245.11 Million ≈ $286.56 Million	€-69.10 Million ≈ $-80.78 Million	-0.282x	-78.03%
2023-12-31	€157.51 Million ≈ $184.14 Million	€-24.94 Million ≈ $-29.16 Million	-0.158x	+92.12%
2022-12-31	€10.35 Million ≈ $12.10 Million	€-20.78 Million ≈ $-24.30 Million	-2.008x	-28.67%
2021-12-31	€17.79 Million ≈ $20.80 Million	€-27.77 Million ≈ $-32.47 Million	-1.561x	--

About SOLENO THERAPEUT. DL-001

F:6XC Germany Biotechnology

Market Cap

$2.73 Billion

€2.34 Billion EUR

Market Cap Rank

#5608 Global

#884 in Germany

Share Price

€44.86

Change (1 day)

+1.70%

52-Week Range

€25.52 - €73.00

All Time High

€73.10